Misplaced Pages

Calfactant, also known as Infasurf, is an intratracheal suspension derived from the natural surfactant in calf lungs. It is used in premature infants with lung surfactant deficiency that causes infant respiratory distress syndrome (IRDS).

Mechanism of action

Lung surfactant is essential for effective ventilation as it modifies alveolar surface tension. IRDS is caused by a lung surfactant deficiency. Calfactant serves as a substitute for the natural surfactant.

References

1. "Infasurf". Archived from the original on 2011-12-09. Retrieved 2011-12-16.
2. ^ Drugs.com: "Calfactant". Drugs.com.
3. Schurch S, Lee M, Gehr P (1992). "Pulmonary surfactant: Surface properties and function of alveolar and airway surfactant". Pure and Applied Chemistry. 64 (11): 1745–1750. doi:10.1351/pac199264111745. S2CID 97007574.

This drug article relating to the respiratory system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Drugs not assigned an ATC code
• Surfactants
• Respiratory system drug stubs